Our proprietary high performance nanoliter-scale immunoassay platforms, Gyrolab xPand and Gyrolab xPlore, are used by scientists in leading pharmaceutical, biotech, CRO, and CMO companies

Bioanalytical applications include pharmacokinetics/pharmacodynamics, immunogenicity, affinity,product titer and quantitating bioprocess-related impurities.

Our Innovation Timeline

1988-1999 Amersham Pharmacia Biotech. Project on miniaturization and microfluidics.

1988-1999

Amersham Pharmacia Biotech. Project on miniaturization and microfluidics.

2000 Gyros AB formed. Spin off from Amersham Pharmacia Biotech.

2000

Gyros AB formed. Spin off from Amersham Pharmacia Biotech.

2002 Gyrolab Maldi SP1. First instrument for purifying protein samples for analysis by MALDI MS.

2002

Gyrolab Maldi SP1. First instrument for purifying protein samples for analysis by MALDI MS.

2003 Gyrolab Workstation and Bioaffy 200 CD

2003

Gyrolab Workstation and Bioaffy 200 CD. First immunoassay system for nanoliter-scale protein quantification launched at DDT in Boston.

2006 One Mouse, One PK

2006

Cambridge Antibody Technologies (now Medimmune) purchases first system for use in biotherapeutic development.

Download Case Study: One Mouse, One PK…the Magic of Capillary Microsampling and Gyrolab

Download
2009 Gyrolab xP launched with software designed for 21 CFR part 11 compliance and extended validation support.

2009

Gyrolab xP launched with software designed for 21 CFR part 11 compliance and extended validation support.

2011 Launch of ADA solution. New mixing CD and software for analysis of anti-drug antibodies.

2011

Launch of ADA solution. New mixing CD and software for analysis of anti-drug antibodies.

2014 Gyrolab Protein A kit launched.

2014

Gyrolab Protein A kit launched.

2015 Gyrolab xPlore launched

2015

Gyrolab xPlore launched, a single CD compact alternative to the Gyrolab xP.

Gyrolab CHO-HCP and huIgG titer kits expand the bioprocess kit menu.

2016 Gyrolab Affinity software launched. Gyros Protein Technologies formed by the merger of Gyros AB and Protein Technologies, Inc.

2016

Gyrolab Affinity software launched.

Gyros Protein Technologies formed by the merger of Gyros AB and Protein Technologies, Inc.

2017 Launch of  Gyrolab Generic PK Kit, New ADA solution and Updated Protein A Kit

2017

Launch of

  • Gyrolab Generic PK Kit
  • New ADA solution
  • Updated Protein A Kit

 

2018 Launch of Gyrolab xPand

2018

Launch of Gyrolab xPand

  • Cooling of samples and reagents
  • Mix and match methods/CDs in a single run

 

2019 Gyros Protein Technologies is now a division of Mesa Laboratories

2019

Launch of:

  • Gyrolab E. coli HCP Kit
  • Gyrolab CHO-HCP E3G Kit
  • Gyrolab p24 Kit
  • Gyrolab Bioaffy 1000 HC Assay Toolbox

Acquisition of Gyros Protein Technologies by Mesa Laboratories, Inc.

  • Gyros Protein Technologies is now a division of Mesa Laboratories
2020 Launch of Gyrolab® AAV Titer Kit and Gyrolab® Bioaffy™ 1000 HC

2020

Gyrolab® AAV Titer Kit
Accelerate AAV vector titer measurement with 10x less samples

Gyrolab® Bioaffy 1000 HC
Improved performance for low affinity reagents

2021 Launch of Gyrolab® Bioaffy™ 4000 CD and Ready to use solutions for Gyrolab with reagent sets for Gyrolab.

2021

Gyrolab® Bioaffy™ 4000 CD
for increased immunoassay sensitivity

Launch of:
Ready to use Solutions for Gyrolab® with reagent sets from Cygnus that are developed for use with the Gyrolab technology.

HEK 293 HCP Solution for Gyrolab®, EndonucleaseGTP® Solution for Gyrolab®, and CHO HCP 3G Solution for Gyrolab®

Rexxip Scouting Pack and Gyrolab Human Cytokine Kit Reagents

2022

Launch of: 

Rexxip™ Scounting Pack

5 mL of each of the following buffers: Rexxip A, AN, H, HN, HX. 

Gyrolab Human Cytokine Kit Reagents

Gyrolab cytokine kit reagents are available for quantification of IL-4, IL-6, IL-10, IFN-gamma and TNF-alpha in human serum down to low pg/mL levels using the Gyrolab Bioaffy™ 4000 CD